OBJECTIVES: We investigated the contribution of gestational diabetes mellitus (GDM) to the historic epidemic of type 2 diabetes mellitus (T2DM) in Saskatchewan. METHODS: We constructed a population-level simulation model of the inter- and intragenerational interaction of GDM and T2DM for the period 1956 to 2006. The model was stratified by gender, ethnicity, and age; parameterized with primary and secondary data; and calibrated to match historic time series. Risk of diabetes was sigmoidally trended to capture exogenous factors. RESULTS: Best-fit calibrations suggested GDM may be responsible for 19% to 30% of the cases of T2DM among Saskatchewan First Nations people, but only for approximately 6% of cases among other persons living in Saskatchewan. The estimated contribution of GDM to the growth in T2DM was highly sensitive to assumptions concerning the post-GDM risk of developing T2DM. CONCLUSIONS: GDM may be an important driver for the T2DM epidemic in many subpopulations. Because GDM is a readily identifiable, preventable, and treatable condition, investments in prevention, rapid diagnosis, and evidence-based treatment of GDM in at-risk populations may offer substantial benefit in lowering the T2DM burden over many generations. Model-informed data collection can aid in assessing intervention tradeoffs.
OBJECTIVES: We investigated the contribution of gestational diabetes mellitus (GDM) to the historic epidemic of type 2 diabetes mellitus (T2DM) in Saskatchewan. METHODS: We constructed a population-level simulation model of the inter- and intragenerational interaction of GDM and T2DM for the period 1956 to 2006. The model was stratified by gender, ethnicity, and age; parameterized with primary and secondary data; and calibrated to match historic time series. Risk of diabetes was sigmoidally trended to capture exogenous factors. RESULTS: Best-fit calibrations suggested GDM may be responsible for 19% to 30% of the cases of T2DM among Saskatchewan First Nations people, but only for approximately 6% of cases among other persons living in Saskatchewan. The estimated contribution of GDM to the growth in T2DM was highly sensitive to assumptions concerning the post-GDM risk of developing T2DM. CONCLUSIONS: GDM may be an important driver for the T2DM epidemic in many subpopulations. Because GDM is a readily identifiable, preventable, and treatable condition, investments in prevention, rapid diagnosis, and evidence-based treatment of GDM in at-risk populations may offer substantial benefit in lowering the T2DM burden over many generations. Model-informed data collection can aid in assessing intervention tradeoffs.
Authors: Tracey L Weissgerber; Larry A Wolfe; Gregory A L Davies; Michelle F Mottola Journal: Appl Physiol Nutr Metab Date: 2006-12 Impact factor: 2.665
Authors: Lorna E Thorpe; Diana Berger; Jennifer A Ellis; Vani R Bettegowda; Gina Brown; Thomas Matte; Mary Bassett; Thomas R Frieden Journal: Am J Public Health Date: 2005-07-28 Impact factor: 9.308
Authors: Nasim S Sabounchi; Peter S Hovmand; Nathaniel D Osgood; Roland F Dyck; Emily S Jungheim Journal: Am J Public Health Date: 2014-05-15 Impact factor: 9.308
Authors: Roland Dyck; Chandima Karunanayake; Punam Pahwa; Louise Hagel; Josh Lawson; Donna Rennie; James Dosman Journal: BMC Public Health Date: 2013-01-05 Impact factor: 3.295